Categories: News

Chemesis International Inc. Announces Agreement with The Pelican Group, a Leading Vending & Amusement Management Company

VANCOUVER, BC / ACCESSWIRE / February 23, 2021 / Chemesis International Inc. (CSE:CSI.U)(OTCQB:CADMF)(FRA: CWAB) (the “Company” or “Chemesis”), announces that it has reached an agreement with The Pelican Group, a leading Vending & Amusement Management Company, to deploy CBD Vending machines to locations nationwide.

Pelican has been associated with the coin-op industry for 49 years. Their management team is perfectly aligned to oversee and administer the entire Chemesis program and will act as the main contact for operators selected to participate.

Richard Scherer, President of Pelican, commented, “Chemesis has been great to work with and we are excited to move forward with this new venture. We will be working with outstanding operators from all over the country who will benefit from this opportunity. We have worked with Josh Rosenberg over the years and are proud to be partnered with his Team yet again to bring their market-leading CBD vending machine to market. “It’s always a pleasure working with a company providing innovative products that contribute to the operator’s bottom line.”

On Behalf of The Board of Directors
Josh Rosenberg
President

About the Pelican Group

The Pelican Group manages over 50,000 pieces of coin-operated music, amusement and vending equipment for corporate clients through a network of more than 600 professional local coin-machine operators. With offices across the country, they offer a single source of contact, contract administration and accounting for clients with locations in multiple geographical regions.

A privately held California corporation, Pelican’s principal office is in Danville, CA.

has approved a marketing budget of US $1,318,943 with CDMG Inc. (“CDMG”). CDMG will provide the Company with marketing services utilizing its skills to generate investor awareness and attract new investors thru its platforms.

About Chemesis International Inc.

Chemesis International Inc. is a U.S. focused multi-state cannabis company, that is focused on providing an artificially intelligent (AI) based retail solution. The Company currently holds exclusive rights to an AI based kiosk which can be deployed in high traffic areas such as, shopping malls, stadiums, transit hubs, workplaces, and large corporate headquarters.

Chemesis and its team are committed to building a strong unattended and attended retail model for the cannabis market across the United States. Chemesis’ retail brand, Green Spirit Rx, will continue to provide consumers with industry-leading technology, the most sought-after products and education.

Investor Relations:

ir@chemesis.com
1 (604) 398-3378

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its supply and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distribution arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release

SOURCE: Chemesis International Inc.

View source version on accesswire.com:
https://www.accesswire.com/631197/Chemesis-International-Inc-Announces-Agreement-with-The-Pelican-Group-a-Leading-Vending-Amusement-Management-Company

Staff

Recent Posts

Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024

LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally…

7 hours ago

Free Dementia Training in Alabama

Bring Dementia Education at No Cost to Your Skilled Nursing HomeTUSCALOOSA, AL / ACCESSWIRE /…

7 hours ago

Accuryn Medical Announces Maclean Health FSS Contract Award

Accuryn Monitor Now Included in Department of Veteran Affairs (VA) Federal Supply Schedule (FSS)HAYWARD, CA…

10 hours ago

Southern Illinois Associates Selects eClinicalWorks Cloud EHR for Comprehensive Behavioral Health Tools

The psychiatry and behavioral health group to utilize practice management and patient engagement solutions to…

13 hours ago

Nym Named Among Top 25 Companies in Healthcare Software for 2024 by The Healthcare Technology Report

NEW YORK--(BUSINESS WIRE)--Nym, the leader in autonomous medical coding, today announced that it has been…

13 hours ago